Skip to content

A comparative study of three types of rehabilitation interventions for autism spectrum disorders

A comparative study of three types of rehabilitation interventions for autism spectrum disorders

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17013217
Enrollment
Unknown
Registered
2017-11-02
Start date
2017-11-15
Completion date
Unknown
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autism spectrum disorders

Interventions

TEACCH group:Treatment and Education of Autistic and related Communication handicapped Children
ESDM group:Early Start Denver Model
DTT group:Discrete Trial Teaching

Sponsors

the First Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 5 Years

Inclusion criteria

Inclusion criteria: 1. Conform to diagnostic criteria of the dsm-v for autism spectrum disorder; 2. Between the ages of 2 and 5; 3. There are no Rett syndrome, fragile X syndrome, hereditary metabolic disease, and the combination of epilepsy.;Inclusion criteria: 1. Conform to diagnostic criteria of the dsm-v for autism spectrum disorder; 2. Between the ages of 2 and 5; 3. There are no Rett syndrome, fragile X syndrome, hereditary metabolic disease, and the combination of epilepsy.;Inclusion criteria: 1. Conform to diagnostic criteria of the dsm-v for autism spectrum disorder; 2. Between the ages of 2 and 5; 3. There are no Rett syndrome, fragile X syndrome, hereditary metabolic disease, and the combination of epilepsy.;Inclusion criteria: 1. Conform to diagnostic criteria of the dsm-v for autism spectrum disorder; 2. Between the ages of 2 and 5; 3. There are no Rett syndrome, fragile X syndrome, hereditary metabolic disease, and the combination of epilepsy.;Inclusion criteria: 1. Conform to diagnostic criteria of the dsm-v for autism spectrum disorder; 2. Between the ages of 2 and 5; 3. There are no Rett syndrome, fragile X syndrome, hereditary metabolic disease, and the combination of epilepsy.

Exclusion criteria

Exclusion criteria: 1. Not conforming to the above inclusion criteria; 2. Less than 2 years old or more than 5 years old; 3. Children with uncontrollable seizures; 4. The patient or patient's guardian refuses to evaluate or interrupt the treatment.;Exclusion criteria: 1. Not conforming to the above inclusion criteria; 2. Less than 2 years old or more than 5 years old; 3. Children with uncontrollable seizures; 4. The patient or patient's guardian refuses to evaluate or interrupt the treatment.;Exclusion criteria: 1. Not conforming to the above inclusion criteria; 2. Less than 2 years old or more than 5 years old; 3. Children with uncontrollable seizures; 4. The patient or patient's guardian refuses to evaluate or interrupt the treatment.;Exclusion criteria: 1. Not conforming to the above inclusion criteria; 2. Less than 2 years old or more than 5 years old; 3. Children with uncontrollable seizures; 4. The patient or patient's guardian refuses to evaluate or interrupt the treatment.;Exclusion criteria: 1. Not conforming to the above inclusion criteria; 2. Less than 2 years old or more than 5 years old; 3. Children with uncontrollable seizures; 4. The patient or patient's guardian refuses to evaluate or interrupt the treatment.

Design outcomes

Primary

MeasureTime frame
Autism Behavior Check;Childhood Autism Rating Scale;Autism Treatment Evaluation Checklist;Psychoeducational Profile (Third Edition);Gesell Developmental Scales;

Countries

China

Contacts

Public ContactFeiyong Jia;Feiyong Jia;Feiyong Jia;Feiyong Jia;Feiyong Jia ;;;;

the First Hospital of Jilin University;the First Hospital of Jilin University;the First Hospital of Jilin University;the First Hospital of Jilin University;the First Hospital of Jilin University

erkekangfujia@163.com;erkekangfujia@163.com;erkekangfujia@163.com;erkekangfujia@163.com;erkekangfujia@163.com+86 13943003914;+86 13943003914;+86 13943003914;+86 13943003914;+86 13943003914

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026